NCT06722820View on ClinicalTrials.gov

Study to Evaluate LPH-5 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

Safety IssuesTolerance

Interventions

DRUG

LPH-5

LPH-5

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Biotrial

INDUSTRY

lead

Lophora

INDUSTRY

NCT06722820 - Study to Evaluate LPH-5 in Healthy Subjects | Biotech Hunter | Biotech Hunter